Petrovax presents its new product Gialera®
A new product by Petrovax is coming into the market: Gialera® is an innovative combination of components, which provides a comprehensive approach to manage heartburn.
Gialera® includes sodium alginate to reduce discomfort caused by heartburn, and hyaluronic acid for mucosal repair and protection in the stomach and esophagus.
From 20% to 50% of people living in developed countries have heartburn which is caused by the involuntary flow of stomach content back into the esophagus. If heartburn occurs rarely, it usually disappears when a person changes lifestyle. However, if it occurs regularly, a comprehensive approach is important: treating symptoms and restoring mucosa.
Sodium alginate in Gialera® helps to reduce discomfort caused by heartburn, stomach heaviness, acid reflux and other conditions with increased acid production. Gialera® creates a gel "barrier" in the stomach, which prevents acid content of the stomach from getting into the esophagus, and absorbs aggressive components of gastric acid.
High-molecular-weight hyaluronic acid promotes mucosal repair and protection in the stomach and esophagus, reducing its sensitivity, as well as the number and intensity of frequent heartburn, and discomfort.
The product has pear scent and flavor, and is produced in a convenient form of stick packs, filled with the suspension which is ready for use. It is recommended to take Gialera® immediately after a meal, in 15-30 minutes.
Gialera® is a dietary supplement*, produced in Europe in accordance with international GMP standards.
Petrovax starts product supply to Russia in May.
*Dietary supplement. NOT A DRUG.
1. A. Dorofeev, E. Dyadyk, T. Zvyagintseva, Y. Chichula, N. Rudenko, A. Stukalo. New opportuinities in gastroesophageal reflux disease treatment. Medicines. Modern gastroenterology. 2019; 5 (109): 51-58.
2. D. Clarret, K. Hachem. Gastroesophageal reflux disease (GERD). Mo Med. 2018; 115(3):214-218. PMID: 30228725; PMCID: PMC6140167
3. T. Zvyagintseva, A. Chernobai. New prospects in gastroesophageal reflux disease treatment. Health of Ukraine. Gastroenterology: clinical achievements. 019; 3(53): 28-29.
4. Mandel, Daggy, Brodie, & Jacoby. (2000). Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Alimentary Pharmacology and Therapeutics, 14(6), 669–690. doi:10.1046/j.1365-2036.2000.00759.x